Cargando…

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer

Multidrug resistance (MDR) is a major impediment to cancer treatment. Here, for the first time, we investigated the chemo-sensitizing effect of Noscapine (Nos) at low concentrations in conjunction with docetaxel (DTX) to overcome drug resistance of triple negative breast cancer (TNBC). In vitro expe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doddapaneni, Ravi, Patel, Ketan, Chowdhury, Nusrat, Singh, Mandip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696458/ https://www.ncbi.nlm.nih.gov/pubmed/29158480 http://dx.doi.org/10.1038/s41598-017-15531-1

Ejemplares similares

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers
por: Cheriyan, Vino T., et al.
Publicado: (2016)

Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine
por: Andey, Terrick, et al.
Publicado: (2016)

Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS)
por: Lacey, Alexandra, et al.
Publicado: (2016)

Enhanced Anticancer Activity of Gemcitabine in Combination with Noscapine via Antiangiogenic and Apoptotic Pathway against Non-Small Cell Lung Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Curcuma zedoaria petroleum ether extract reverses the resistance of triple-negative breast cancer to docetaxel via pregnane X receptor
por: Qiao, En-Qi, et al.
Publicado: (2021)

ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line
por: Hwang, Eunjoo, et al.
Publicado: (2018)

Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid
por: Godugu, Chandraiah, et al.
Publicado: (2014)

Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
por: Li, Shenduo, et al.
Publicado: (2015)

Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance
por: Mohseni, Mahsa, et al.
Publicado: (2016)

Inhibition of p38 MAPK increases the sensitivity of 5-fluorouracil-resistant SW480 human colon cancer cells to noscapine
por: Han, Zheng, et al.
Publicado: (2022)

KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells
por: Jiang, Meng, et al.
Publicado: (2017)

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

Engineering biosynthesis of the anticancer alkaloid noscapine in yeast
por: Li, Yanran, et al.
Publicado: (2016)

Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
por: Li, Xinyang, et al.
Publicado: (2022)

Biological Evaluation of Noscapine analogues as Potent and Microtubule-Targeted Anticancer Agents
por: Tomar, Vartika, et al.
Publicado: (2019)

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)

Deciphering the Binding Mechanism of Noscapine with Lysozyme: Biophysical and Chemoinformatic Approaches
por: Sood, Damini, et al.
Publicado: (2019)

Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
por: Luty, Marcin, et al.
Publicado: (2019)

Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling
por: Fatima, Iram, et al.
Publicado: (2019)

Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies
por: Kanwal, Bushra
Publicado: (2021)

Comparative evaluation of anti-angiogenic effects of noscapine derivatives
por: Meher, Rajesh K., et al.
Publicado: (2018)

Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism
por: Yin, Delong, et al.
Publicado: (2021)

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
por: Zhou, Hai-Hong, et al.
Publicado: (2019)

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023)

MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
por: Li, Yaming, et al.
Publicado: (2018)

Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells
por: Byun, Woong Sub, et al.
Publicado: (2021)

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
por: Molavi, Ommoleila, et al.
Publicado: (2016)

Apoptosis induction of human endometriotic epithelial and stromal cells by noscapine
por: Khazaei, Mohammad Rasoul, et al.
Publicado: (2016)

Detection of Heroin and Noscapine in Bile Specimen in a Body Packer
por: NAJAFI, Nahid, et al.
Publicado: (2019)

Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review
por: Rahmanian-Devin, Pouria, et al.
Publicado: (2021)

Inhibition of Myeloperoxidase Pro-Fibrotic Effect by Noscapine in Equine Endometrium
por: Amaral, Ana, et al.
Publicado: (2023)

Reversible Adaptive Plasticity: A Mechanism for Neuroblastoma Cell Heterogeneity and Chemo-Resistance
por: Chakrabarti, Lina, et al.
Publicado: (2012)

HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer
por: Mao, Misha, et al.
Publicado: (2022)

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
por: Tang, Amy H., et al.
Publicado: (2022)

Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Krüppel-like factor 5 in triple-negative breast cancer
por: Li, Zhen, et al.
Publicado: (2016)

Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors
por: Campani, Virginia, et al.
Publicado: (2022)

Mechanism-Based Sonodynamic–Chemo Combinations against Triple-Negative Breast Cancer
por: Feng, Xiaolan, et al.
Publicado: (2022)

Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma
por: Köritzer, Julia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lonlpmpnk09lcthi3k4d9h0s10